Mongoose Bio
Pre-clinicalMongoose Bio is an early-stage clinical company revolutionizing the delivery of T cell precision therapies against common and rare solid tumors. Mongoose Bio has developed a unique and disruptive approach to adoptive T cell therapies using epigenetic reprogramming of autologous Tcm cells harboring defined TCRs against empirically-validated, highly-immunogenic tumor targets to generate active and persistent TCR-T therapeutics. This approach has several distinct advantages:
About
Mongoose Bio is an early-stage clinical company revolutionizing the delivery of T cell precision therapies against common and rare solid tumors. Mongoose Bio has developed a unique and disruptive approach to adoptive T cell therapies using epigenetic reprogramming of autologous Tcm cells harboring defined TCRs against empirically-validated, highly-immunogenic tumor targets to generate active and persistent TCR-T therapeutics. This approach has several distinct advantages:
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile